In this task, you are given a summary for US Congressional and California state bill, your task is to generate a Title for this bill. The preferred titles are under forty words and mention the purpose of the bill.

Q: Verifying Authority and Legality In Drug Compounding Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) with respect to the regulation of compounding drugs.

Eliminates authority for compounding pharmacies to: (1) compound drugs before the receipt of a valid prescription order, or (2) compound any drug product that is a copy of a commercially available drug.

Requires the Secretary of Health and Human Services (HHS) to develop, maintain and transmit to the appropriate state agencies a list of drug products that should not be compounded, including: (1) drug products whose compounding is reasonably likely to cause an adverse effect on their safety or effectiveness; and (2) drug products that have been withdrawn or removed from the market because they have been found to be unsafe or not effective.

Authorizes the Secretary to waive the requirement that a drug product must be compounded for an individually identified patient based on a valid prescription order or similar notation if compounding the drug product is necessary to address a drug shortage, or to protect public health or well-being. Prohibits the Secretary from authorizing a state to grant such waivers.

Authorizes the Secretary to waive the requirement that a drug product must be compounded for an individually identified patient based on a valid prescription order or similar notation if the pharmacy or pharmacist: (1) submits a satisfactory application to the Secretary; and (2) agrees to comply with any condition or limitation specified by the Secretary. Makes a pharmacy or pharmacist required to be registered under the FFDCA as a drug producer ineligible for a waiver. Permits the Secretary to authorize a state to grant such waivers applicable to compounded drug products sold or dispensed within the state pursuant to a memorandum of understanding between the Secretary and the state.

Authorizes the Secretary to waive the prohibition against compounding any drug product that is a copy of a commercially available drug if it is necessary to protect public health or well-being. Prohibits the Secretary from authorizing a state to waive such prohibition.

Subjects the facilities of any pharmacy receiving a waiver under this Act to inspection to determine compliance with this Act.

Requires the Secretary to publish notice at least 30 days before cancelling a waiver, unless it is necessary to prevent an adverse impact on public health or safety.

Sets forth a required label statement for any drug compounded pursuant to this Act.

Requires a pharmacist or physician compounding a drug product to report any adverse event associated with the use of the product within a specified time frame.

A: To amend the Federal Food, Drug, and Cosmetic Act to provide for the compounding of drug products.
****
Q: Environmentally Responsible Windpower Act of 2005 - States that an onshore and above-water wind turbine project must file with the Federal Energy Regulatory Commission (FERC) its Local Approval Authorization (a resolution of approval or denial from the local governing body and local senior executive) prior to FERC issuance of its Exempt-Wholesale Generator Status, Market-Based Rate Authority, or Qualified Facility rate schedule. Prohibits FERC from issuing any of them to a wind project if the local authorities deny the siting of the project.

A: A bill to provide for local control for the siting of windmills.
****
Q: National Bank Offshore Activities Act of 2001 - Amends Federal banking law to subject activities, investments, and affiliations of national banks to certain reporting requirements without regard to any territorial limitation.Sets forth reporting requirements incumbent upon a national bank with respect to: (1) acquisition of a beneficial interest in an offshore company; and (2) violations of banking, financial services, or labor laws committed by its agents, affiliates, or any other entity with which it maintains a correspondent banking relationship.Authorizes the Comptroller of the Currency to issue a cease and desist order: (1) prohibiting a national bank from further involvement with such violators; and (2) requiring the bank to dispose of ownership interests in such entity.States that any foreign bank having a Federal branch or agency shall be treated as a national bank for purposes of this Act.

A:
To amend banking laws with respect to offshore activities, investments, and affiliations of national banks, and for other purposes.
****